BPC-157 Research for Tendonitis
An evidence-based overview of research examining BPC-157 in the context of tendonitis. This page synthesizes findings from peer-reviewed literature.
Research Summary
BPC-157 has been studied for its potential effects on tendon healing in preclinical models. Research from Taiwanese laboratories demonstrated that BPC-157 promotes tendon fibroblast proliferation and migration through FAK-paxillin pathway activation (Chang et al., 2011). However, all available evidence is preclinical. No human clinical trials have evaluated BPC-157 for tendonitis.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Tendonitis
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. BPC-157 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.